Brenig Therapeutics Advances Two CNS Programs Into...
Category : Clinical Trial Update 20 January 2026Brenig Therapeutics has initiated a first-in-human (FIH) Phase 1 study for BT-409, its brain-selecti...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Brenig Therapeutics has initiated a first-in-human (FIH) Phase 1 study for BT-409, its brain-selecti...
A major international research effort is testing whether a simple finger-prick blood test can help d...
Boston Scientific Corporation has agreed to acquire Penumbra, Inc. in a cash-and-stock transaction v...
Miach Orthopaedics has secured FDA 510(k) clearance for updated labelling of its BEAR Implant, marki...
Zylox-Tonbridge, a Hong Kong-listed medical technology company, has signed a definitive agreement to...